[go: up one dir, main page]

AU681341B2 - Protective effects of mutated superantigens - Google Patents

Protective effects of mutated superantigens Download PDF

Info

Publication number
AU681341B2
AU681341B2 AU36005/93A AU3600593A AU681341B2 AU 681341 B2 AU681341 B2 AU 681341B2 AU 36005/93 A AU36005/93 A AU 36005/93A AU 3600593 A AU3600593 A AU 3600593A AU 681341 B2 AU681341 B2 AU 681341B2
Authority
AU
Australia
Prior art keywords
superantigen
seb
cell
cells
mhc
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU36005/93A
Other languages
English (en)
Other versions
AU3600593A (en
Inventor
John W Kappler
Philippa Marrack
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
National Jewish Health
Original Assignee
National Jewish Center for Immunology and Respiratory Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by National Jewish Center for Immunology and Respiratory Medicine filed Critical National Jewish Center for Immunology and Respiratory Medicine
Publication of AU3600593A publication Critical patent/AU3600593A/en
Application granted granted Critical
Publication of AU681341B2 publication Critical patent/AU681341B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N37/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
    • A01N37/18—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing the group —CO—N<, e.g. carboxylic acid amides or imides; Thio analogues thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Agronomy & Crop Science (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Superconductors And Manufacturing Methods Therefor (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
AU36005/93A 1992-01-28 1993-01-28 Protective effects of mutated superantigens Ceased AU681341B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US82754092A 1992-01-28 1992-01-28
US827540 1992-01-28
PCT/US1993/000839 WO1993014634A1 (fr) 1992-01-28 1993-01-28 Effets protecteurs de superantigenes ayant subi une mutation

Publications (2)

Publication Number Publication Date
AU3600593A AU3600593A (en) 1993-09-01
AU681341B2 true AU681341B2 (en) 1997-08-28

Family

ID=25249482

Family Applications (1)

Application Number Title Priority Date Filing Date
AU36005/93A Ceased AU681341B2 (en) 1992-01-28 1993-01-28 Protective effects of mutated superantigens

Country Status (6)

Country Link
EP (1) EP0626805A4 (fr)
JP (1) JPH08500328A (fr)
KR (1) KR950700005A (fr)
AU (1) AU681341B2 (fr)
CA (1) CA2128415A1 (fr)
WO (1) WO1993014634A1 (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9402430L (sv) 1994-07-11 1996-01-12 Pharmacia Ab Konjugat mellan modifierat superantigen och en målsökande förening samt användning av konjugaten
WO1996014744A1 (fr) * 1994-11-14 1996-05-23 National Jewish Center For Immunology And Respiratory Medicine Effets protecteurs de superantigenes mutants
AU723116B2 (en) 1995-06-07 2000-08-17 Regents Of The University Of Minnesota Mutants of streptococcal toxin A and methods of use
SE9601245D0 (sv) 1996-03-29 1996-03-29 Pharmacia Ab Chimeric superantigens and their use
TW517061B (en) 1996-03-29 2003-01-11 Pharmacia & Amp Upjohn Ab Modified/chimeric superantigens and their use
US6774218B2 (en) 1996-12-06 2004-08-10 Regents Of The University Of Minnesota Mutants of streptococcal toxin C and methods of use
KR100548663B1 (ko) 1996-12-06 2006-02-03 리전츠 오브 더 유니버스티 오브 미네소타 연쇄상구균 독소 ａ의 돌연변이체
PT946730E (pt) 1996-12-06 2006-06-30 Univ Minnesota Mutantes de toxina estreptococica c e metodos de utilizacao
KR20010034440A (ko) * 1998-02-15 2001-04-25 사코 미츠오 신규한 면역이상성질환의 예방/치료제
CA2339355A1 (fr) 1998-07-10 2000-01-20 U.S. Medical Research Institute Of Infectious Diseases Vaccin du charbon bacteridien
US7491402B2 (en) 1998-12-24 2009-02-17 Auckland Uniservices Limited Superantigens SMEZ-2, SPE-G, SPE-H and SPE-J and uses thereof
NZ519371A (en) 2002-06-04 2004-11-26 Auckland Uniservices Ltd Immunomodulatory constructs and their uses
ATE461277T1 (de) * 2003-03-28 2010-04-15 Chemo Sero Therapeut Res Inst Seb-modifikation und diese enthaltendes vorbeugendes mittel/heilmittel gegen krankheiten mit einer immunanomalität
WO2005023853A1 (fr) 2003-09-05 2005-03-17 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute Variante de l'enterotoxine b du staphylocoque dore resistant aux proteases et vaccin en contenant
KR20220132641A (ko) * 2020-12-18 2022-09-30 비오메디찌니쉐 포르슝 운트 바이오-프로듀테 아게 보호성 스타필로코커스 외독소 백신

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69133485T2 (de) * 1990-01-17 2006-06-22 Terman, David S., Pebble Beach Verwendung von Staphylococcus Enterotoxin Homologe für Krebs-Therapie

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
BUELOW, R ET AL. (1992) J. IMMUNOL., 148(1), 1-6 *
MARRICK, P ET AL. (1990) J. EXP. MED, 171, 455-464 *

Also Published As

Publication number Publication date
CA2128415A1 (fr) 1993-08-05
WO1993014634A1 (fr) 1993-08-05
EP0626805A1 (fr) 1994-12-07
KR950700005A (ko) 1995-01-16
AU3600593A (en) 1993-09-01
JPH08500328A (ja) 1996-01-16
EP0626805A4 (en) 1995-12-06

Similar Documents

Publication Publication Date Title
AU681341B2 (en) Protective effects of mutated superantigens
Kappler et al. Mutations defining functional regions of the superantigen staphylococcal enterotoxin B.
RU2138512C1 (ru) Вакцина для профилактики или лечения опосредованной т-клетками патологии или нерегулируемой репликации клонами т-клеток, способ выделения вакцины, способ диагностирования или прогнозирования восприимчивости к ревматоидному артриту или рассеянному склерозу, способ профилактики или лечения ревматоидного артрита или рассеянного склероза и содержащий последовательность sgdqggne пептид, являющийся агентом для обнаружения, профилактики или лечения рассеянного склероза
CA2412504C (fr) Polypeptides antigenes
Lindler et al. Cloning of a Brucella melitensis group 3 antigen gene encoding Omp28, a protein recognized by the humoral immune response during human brucellosis
WO1996013593A2 (fr) Recepteurs de lymphocites t monocatenaires solubles
AU2001274248A1 (en) Antigenic polypeptides
EP1037650B1 (fr) Compositions pour le traitement d&#39;infections a staphylococcus aureus
AU2642392A (en) Valpha12.1 t-cell receptor-specific reagents for diagnosing and treating rheumatoid arthritis
CZ280743B6 (cs) Imunogen proti lymské boreliose savců
Belles et al. Bias in the γ δ T cell response to Listeria monocytogenes. V δ 6.3+ cells are a major component of the γ δ T cell response to Listeria monocytogenes
WO1995021926A1 (fr) Induction d&#39;une tolerance au moyen de proteines de fusion tolerogenes
Deringer et al. Subtype‐specific interactions of type C staphylococcal enterotoxins with the T‐cell receptor
US20160074497A1 (en) Staphylococcus live cell vaccines
AU735112B2 (en) Novel polynucleotides and polypeptides in pathogenic mycobacteria and their use as diagnostics, vaccines and targets for chemotherapy
Smulian et al. Isolation and characterization of a recombinant antigen of Pneumocystis carinii
AU6950198A (en) Peptides useful for reducing symptoms of toxic shock syndrome
HUT67654A (en) Method of producing antibodies to a restricted population of t-lymphocytes, antibodies and method of use
Zhou et al. A cross-reactive idiotope on T cells from PL/J mice and Lewis rats that recognizes different myelin basic protein encephalitogenic epitopes but is restricted by TCR V beta 8.2.
WO1996014744A1 (fr) Effets protecteurs de superantigenes mutants
Riding et al. Identification of novel protective antigens from Anaplasma marginale
Born et al. Bias in the y6 T Cell Response to Listeria monocytogenes
CA2163438A1 (fr) Regulateur d&#39;hemolysine controlee par contact
WO1994022474A1 (fr) Procede de traitement du syndrome de kawasaki par modulation immunitaire
JPH10201484A (ja) 新規ＦｔｓＬ